¿Qué son las Células Madre Mesenquimales (MSC)?

Mexico has become a global leader in regenerative medicine due to its advanced legal framework and high-tier specialized clinics. At Clínica Carell in Merida, we adhere to the highest standards by focusing on Mesenchymal Stem Cells (MSCs). Our protocols are educational and evidence-based, ensuring that every patient understands the multipotent nature of the cells—their ability to differentiate into bone or cartilage and their vital role in immunomodulation. When choosing a provider, international patients should prioritize clinics that hold proper sanitary licenses, use certified laboratory-grade cells, and provide a comprehensive medical assessment.

The primary goal of Intravenous (IV) Mesenchymal Stem Cell (MSC) therapy is to promote systemic homeostasis and address chronic inflammation. When administered intravenously, these multipotent cells travel through the bloodstream, responding to chemical signals of distress—a process known as "homing." Their main functions include: Systemic Immunomodulation: They help regulate the immune system, making them an educational cornerstone for patients with chronic inflammatory conditions. Cellular Signaling: MSCs release paracrine factors and exosomes that stimulate the body's own repair mechanisms. Longevity & Revitalization: By reducing the "inflammaging" (age-related chronic inflammation) process, they support overall cellular health and organ function optimization.

Clinical evidence and biological studies suggest that Mesenchymal Stem Cells (MSCs) are highly effective in managing joint pain and promoting tissue repair. Their effectiveness is rooted in two main biological processes: Cartilage Differentiation: As multipotent cells, MSCs have the potential to differentiate into chondrocytes (cartilage cells), supporting the natural restoration of the joint surface. Anti-inflammatory Signaling: The true strength of MSCs lies in their immunomodulatory capacity. They release bioactive molecules that neutralize chronic inflammation, which is the primary cause of pain in conditions like osteoarthritis or sports injuries. For many patients, this therapy represents a viable, non-surgical alternative to knee replacement, offering significant improvements in mobility and quality of life without the risks of invasive procedures.

In advanced regenerative medicine, dosage is not a "one-size-fits-all" approach; it is strictly determined by the patient's weight, the severity of the condition, and the route of administration. For Localized Joint Treatment: Clinical protocols typically range from 10, 25 to 50 million Mesenchymal Stem Cells (MSCs) per joint to ensure an optimal concentration for tissue signaling and repair. For Systemic IV Therapy: Evidence-based international standards often suggest between ranging from 100 to 200 million cells depend on weight and quality of life. Our priority is your safety and the viability of the cells. The only way to ensure a successful outcome is through a personalized medical assessment where we tailor the protocol to your unique biological needs.

Absolutely. Mesenchymal Stem Cell (MSC) therapy is a proven, highly effective solution for knee cartilage wear and osteoarthritis. The therapy works by neutralizing chronic inflammation and signaling the body to begin a natural repair process, effectively restoring joint function. Merida is now a global hub for this procedure due to: High-Tier Medical Standards: At Clínica Carell, we offer international-grade MSC protocols with cell counts and viability levels that meet or exceed those found in the US and Canada. Non-Surgical Focus: Our goal is to provide a viable alternative to knee replacement surgery, allowing patients to regain their mobility with zero downtime. Medical Tourism Excellence: Merida offers a unique combination of world-class medical facilities, safety, and a healing environment, making it the top choice for regenerative orthopedics in Latin America.